Carl LeBel
2021
In 2021, Carl LeBel earned a total compensation of $2.8M as Chief Development Officer at Korro Bio.
Compensation breakdown
| Non-Equity Incentive Plan | $157,035 |
|---|---|
| Option Awards | $1,831,138 |
| Salary | $461,869 |
| Stock Awards | $286,200 |
| Other | $14,500 |
| Total | $2,750,743 |
LeBel received $1.8M in option awards, accounting for 67% of the total pay in 2021.
LeBel also received $157K in non-equity incentive plan, $461.9K in salary, $286.2K in stock awards and $14.5K in other compensation.
Rankings
In 2021, Carl LeBel's compensation ranked 4,776th out of 12,406 executives tracked by ExecPay. In other words, LeBel earned more than 61.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,776 out of 12,406 | 62nd |
Division Manufacturing | 1,990 out of 5,492 | 64th |
Major group Chemicals And Allied Products | 839 out of 2,368 | 65th |
Industry group Drugs | 751 out of 2,089 | 64th |
Industry Pharmaceutical Preparations | 537 out of 1,536 | 65th |
Source: SEC filing on April 29, 2022.
LeBel's colleagues
We found two more compensation records of executives who worked with Carl LeBel at Korro Bio in 2021.